HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mortel, R. Articles by Brady, L. W. Search for Related Content PubMed PubMed Citation Articles by Mortel, R. Articles by Brady, L. W.

MALIGNANT MIXED MÜLLERIAN TUMORS OF THE UTERINE CORPUS

From the Departments of Obstetrics and Gynecology, Pathology, and the Section of Radiation Therapy and Nuclear Medicine of the Department of Radiology, Hahnemann Medical College and Hospital, Phila, Pa.
*Fellow in Gynecologic Oncology, USPHS Clinical Traineeship, No. 27015-01-68

The incidence of malignant mixed müllerian tumors may be greater than indicated by most reports published up to now. While a very poor prognosis has generally been accepted, with only 26 survivors for 5 years being reported to date, the outlook may be improved by adequate radiation dosage to the pelvic structures. The tendency to metastasize widely outside the primary site is a major factor in the poor tumor control. Seven patients' treatment for this disease and their follow-up are reported. One patient who survived 5 years following radiation therapy alone is noted. One other patient who completed treatment by radiation and operation is still living, free of disease, 17 months later.